ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2213

Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis

Vanshika Sabharwal, and Dr Ashit syngle and Dr Inderjeet Verma, MMDU, Mullana, Ambala India and Healing Touch city clinic, Chandigarh, India, Chandigarh, Chandigarh, India

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Cardiovascular, Disease-Modifying Antirheumatic Drugs (Dmards), Mortality, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: RA is a chronic inflammatory disease associated with an excessive premature cardiovascular morbidity and mortality. Endothelial dysfunction is a significant contributor to CVD in RA patients, affecting both microvascular and macrovascular systems. Studying the correlation between microvascular and macrovascular endothelial dysfunction is crucial as macrovascular endothelial dysfunction predicts cardiovascular events in pre-existing atherosclerosis patients, while microvascular function predicts cardiovascular events in patients without vascular pathology1. However, the relationship between microvascular and macrovascular endothelial dysfunction needs exploration.

Objectives:To investigate the correlation between Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis.

Methods: 242 consecutive RA patients (216 females, 26 males; mean age: 54±11, years; range:25 to 82 years) meeting ACR/EULAR 2010 Rheumatoid Arthritis classification criteria on stable doses of cDMARDs swere enrolled. Macrovascular endothelial function was assessed using flow mediated dilation (FMD) at brachial artery using AngioDefender. The Peripheral Perfusion Index (PPI) using Pulse oximeter was used to assess microvascular endothelial function, assessing before and after reactive hyperemia and during periods of Nitric Oxide (NO) vasodilation, and every 15 seconds for 5 minutes.

The variation in the PPI was calculated at each assessed time point using the following formula:

ΔPPI: PPI time − PPI basal/PPI basal (×100)

The relationship between FMD and PPI values was analyzed using Pearson correlation coefficients using graph pad prism3 software.

Results: Research indicates that RA patients exhibit significant endothelial dysfunction in macrovascular compartments and no correlation in microvascular compartments(Table: 1). There was positive correlation (r= -0.109, p= 0.013) observed between FMD values and disease activity scores in macrovascular endothelial dysfunction in RA patients. No statistically significant correlation (r = 0.080, p =0.215) was found between FMD and PPI values, suggesting that microvascular and macrovascular endothelial dysfunctions are not closely related in RA  (Fig: 1).

Conclusion: No correlation was observed between microvascular endothelial dysfunction (PPI) and macrovascular endothelial dysfunction (FMD) in patients with Rheumatoid Arthritis suggesting different underlying pathogenic mechanisms.Understanding this relationship is crucial for developing targeted therapeutic strategies aimed at mitigating cardiovascular risk in RA patients. Further research should explore the underlying mechanisms, predictors and potential interventions to address endothelial dysfunction in this population.

Supporting image 1

Table 1: Correlation of clinical, laboratory and disease activity measures with Macrovascular (FMD) & Microvascular (PPI) endothelial dysfunction in patients with RA (N= 242)

Supporting image 2

Figure 1: Correlation between Macrovascular Endothelial dysfunction (FMD) & Microvascular Endothelial Dysfunction (PPI) in Rheumatoid Arthritis


Disclosures: V. Sabharwal: None.

To cite this abstract in AMA style:

Sabharwal V. Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/microvascular-and-macrovascular-endothelial-dysfunction-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microvascular-and-macrovascular-endothelial-dysfunction-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology